$8.870
+0.142 (+1.60%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de MBRX por análisis de gráficos similares
Alphio's MBRX stock price prediction model matches the current Moleculin Biotech Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.95 (+0.85%). The 1-week path is $8.92 (+0.58%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Moleculin Biotech Inc?
Moleculin Biotech Inc (MBRX) is currently not a good buy due to significant risks despite some recent positive indicators. The current price is $8.87, which is drastically lower than the 52-week high of $253.05, indicating a substantial decline. The RSI is at 61.89, suggesting the stock is nearing overbought territory, while the forward P/E ratio is at 0, indicating uncertainty in future earnings. Furthermore, the company has reported a net income loss of $25,399,000 for Q3 2025, which raises concerns about its financial health. The primary risk is the company's cash position, with only $10.317 million available, which may not be sufficient for ongoing operations and trials, especially given the recent stock plunge of over 25% following clinical trial data.
MBRX cerró en $8.87 el Friday, tras subir +1.60%
Moleculin Biotech Inc (MBRX) last closed at $8.8699999, gaining +1.60%. These facts feed the 1-day and 1-week MBRX price prediction above.
Consenso de analistas
Moleculin Biotech Inc (MBRX): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Moleculin Biotech Inc (MBRX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de MBRX, ordenadas por similitud.
Análisis de estacionalidad de MBRX
Historically the probability of a positive November return for MBRX is 0.00%. January offers the highest probability of a positive month at 45.90%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de MBRX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.67 | $0.72 | $0.78 | -91.93% |
| Dec 2026 | $0.91 | $0.92 | $0.93 | -89.64% |
En 2026, se proyecta que Moleculin Biotech Inc (MBRX) oscile entre $0.67 y $0.93.
Previsión mensual de Moleculin Biotech Inc para 2026
En Nov de 2026, se proyecta que Moleculin Biotech Inc promedie $0.72, con un mínimo de $0.67 y un máximo de $0.78.
En Dec de 2026, se proyecta que Moleculin Biotech Inc promedie $0.92, con un mínimo de $0.91 y un máximo de $0.93.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.